• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者报告的结局:为沉默者和被遗忘者呼吁。

Patient Reported Outcomes in Breast Cancer: A Plea for the Silent and Forgotten.

作者信息

Solano Olivia Inez, Withers Cora, Allen Kirsten, Baliski Chris

机构信息

University of British Columbia, Department of Surgery, Kelowna, British Columbia, Canada; BC Cancer, Department of Surgical Oncology, Kelowna, British Columbia, Canada.

BC Cancer, Department of Surgical Oncology, Kelowna, British Columbia, Canada; Queen's University, Department of Medicine, St Kingston, Ontario, Canada.

出版信息

Clin Breast Cancer. 2025 Aug;25(6):544-553. doi: 10.1016/j.clbc.2025.04.006. Epub 2025 Apr 10.

DOI:10.1016/j.clbc.2025.04.006
PMID:40360299
Abstract

BACKGROUND

There are an increasing number of reports addressing patient reported outcomes (PRO's) following breast conserving surgery (BCS) and mastectomy with reconstruction (MR), but few addressing mastectomy alone (MA). Patients' choice of procedure is often preference-based, making PRO's essential to inform decision making. The current research aims to evaluate PRO's associated with all three surgical procedures, along with patient participation rates.

METHODS

Patients with unilateral, nonrecurrent breast cancer were prospectively enrolled in the study (June 2020 to September 2023). Participants received the BREAST-Q (BQ) survey preoperatively (Q1), 2 to 6 weeks (Q2) and 1 year (Q3) postoperatively. Forced multiple regression analyses were performed to compare postoperative BQ scores.

RESULTS

199 patients were eligible, with 73.4% (146/199) participating in the study. While MA had lower satisfaction with breast scores than BCS (B = -11.6), they were equivalent to those of MR (B = -16.5), with similar pathologic and treatment related factors. Physical well being was similar between all three procedures, while psychosocial well being scores were lower following MR (B = -15.5), but not MA. Patient age, BMI, and tumor size variably impacted BQ scores, but preoperative BQ scores independently correlated with postoperative scores across all domains.

CONCLUSION

Patient response rates are consistent with the literature, but require improvement to ensure meaningful conclusions, generalizability of results, and comparisons between studies. Patients undergoing BCS reported the highest satisfaction and quality of life, with MA being noninferior to MR. Efforts to increase patient participation in PRO's are required, especially in those undergoing MA.

摘要

背景

关于保乳手术(BCS)和乳房切除术后重建(MR)后患者报告结局(PRO)的报告越来越多,但关于单纯乳房切除术(MA)的报告却很少。患者对手术方式的选择通常基于个人偏好,因此PRO对于指导决策至关重要。当前研究旨在评估与所有三种手术相关的PRO以及患者参与率。

方法

前瞻性纳入单侧、非复发性乳腺癌患者进行研究(2020年6月至2023年9月)。参与者在术前(Q1)、术后2至6周(Q2)和1年(Q3)接受BREAST-Q(BQ)调查。进行强制多元回归分析以比较术后BQ评分。

结果

199例患者符合条件,73.4%(146/199)参与了研究。虽然MA的乳房评分满意度低于BCS(B = -11.6),但与MR相当(B = -16.5),病理和治疗相关因素相似。三种手术方式的身体幸福感相似,而MR后的心理社会幸福感得分较低(B = -15.5),但MA并非如此。患者年龄、体重指数和肿瘤大小对BQ评分有不同影响,但术前BQ评分在所有领域均与术后评分独立相关。

结论

患者反应率与文献一致,但需要改进以确保得出有意义的结论、结果的可推广性以及不同研究之间的比较。接受BCS的患者报告的满意度和生活质量最高,MA不劣于MR。需要努力提高患者对PRO的参与度,尤其是在接受MA的患者中。

相似文献

1
Patient Reported Outcomes in Breast Cancer: A Plea for the Silent and Forgotten.乳腺癌患者报告的结局:为沉默者和被遗忘者呼吁。
Clin Breast Cancer. 2025 Aug;25(6):544-553. doi: 10.1016/j.clbc.2025.04.006. Epub 2025 Apr 10.
2
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
3
Implants versus autologous tissue flaps for breast reconstruction following mastectomy.乳房切除术乳房再造中假体与自体组织皮瓣的比较。
Cochrane Database Syst Rev. 2024 Oct 31;10(10):CD013821. doi: 10.1002/14651858.CD013821.pub2.
4
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.
5
Different types of implants for reconstructive breast surgery.用于乳房重建手术的不同类型植入物。
Cochrane Database Syst Rev. 2016 May 16;2016(5):CD010895. doi: 10.1002/14651858.CD010895.pub2.
6
Patient-reported outcomes 3 and 18 months after mastectomy and immediate prepectoral implant-based breast reconstruction in the UK Pre-BRA prospective multicentre cohort study.英国Pre - BRA前瞻性多中心队列研究中乳房切除术后3个月和18个月以及即刻胸肌前植入物乳房重建后的患者报告结局。
Br J Surg. 2025 Feb 1;112(2). doi: 10.1093/bjs/znaf032.
7
Risk-reducing mastectomy for the prevention of primary breast cancer.预防性乳房切除术以预防原发性乳腺癌。
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2010 Nov 10(11):CD002748. doi: 10.1002/14651858.CD002748.pub3.
10
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan.年龄对乳房重建术后患者决策后悔的影响:日本的一项多中心合作研究。
Breast Cancer. 2025 May 4. doi: 10.1007/s12282-025-01709-3.